Stay updated on Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision number v3.3.2 is shown, replacing the previous v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T22:00:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The NIH government operating status notice displayed on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T20:00:27.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Minor formatting tweaks and small content updates on the study details page; the core study information and structure remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:50:53.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T04:24:25.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Removed several Neoplasms and Carcinoma-related terms and added a new version identifier v3.1.0. The page now presents fewer taxonomic categories and indicates the updated version.
    Difference
    0.7%
    Check dated 2025-09-28T23:42:09.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.0.2 is now shown, replacing v3.0.1; the Back to Top control was removed.
    Difference
    0.2%
    Check dated 2025-09-14T09:55:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Ovarian Cancer Clinical Trial page.